Towards tuberculosis elimination: an action framework for low-incidence countries
Migliori, G B
de Vries, G
González Ochoa, E R
van der Werf, M J
Abdel Aziz, M
Al Lawati, M R M
Arrazola de Oñate, W
Cirillo, D M
Dahle, U R
De Paoli, L
Dias, H M
Del Granado, M
Pompa, M G
Popescu, G G
Robalo Cordeiro, C
A Torres-Duque, C
van Weezenbeek, C
Vitillo, R J
Raviglione, M C
MetadataShow full item record
JournalEuropean Respiratory Journal
AbstractThis paper describes an action framework for countries with low tuberculosis (TB) incidence (<100 TB cases per million population) that are striving for TB elimination. The framework sets out priority interventions required for these countries to progress first towards "pre-elimination" (<10 cases per million) and eventually the elimination of TB as a public health problem (less than one case per million). TB epidemiology in most low-incidence countries is characterised by a low rate of transmission in the general population, occasional outbreaks, a majority of TB cases generated from progression of latent TB infection (LTBI) rather than local transmission, concentration to certain vulnerable and hard-to-reach risk groups, and challenges posed by cross-border migration. Common health system challenges are that political commitment, funding, clinical expertise and general awareness of TB diminishes as TB incidence falls. The framework presents a tailored response to these challenges, grouped into eight priority action areas: 1) ensure political commitment, funding and stewardship for planning and essential services; 2) address the most vulnerable and hard-to-reach groups; 3) address special needs of migrants and cross-border issues; 4) undertake screening for active TB and LTBI in TB contacts and selected high-risk groups, and provide appropriate treatment; 5) optimise the prevention and care of drug-resistant TB; 6) ensure continued surveillance, programme monitoring and evaluation and case-based data management; 7) invest in research and new tools; and 8) support global TB prevention, care and control. The overall approach needs to be multisectorial, focusing on equitable access to high-quality diagnosis and care, and on addressing the social determinants of TB. Because of increasing globalisation and population mobility, the response needs to have both national and global dimensions.
PublisherEuropean Respiratory Society
- Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
- Authors: Fears R, Kaufmann S, Ter Meulen V, Zumla A, EASAC Working Group.
- Issue date: 2010 May
- [Reform of Japan's NTP and its technical perspectives].
- Authors: Mori T
- Issue date: 2004 Oct
- Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
- Authors: Pablos-Mendez A, Gowda DK, Frieden TR
- Issue date: 2002
- Prevalence of tuberculosis and multidrug resistant tuberculosis in the Middle East Region.
- Authors: Ahmad S, Mokaddas E, Al-Mutairi NM
- Issue date: 2018 Sep
- The Global TB Drug Facility: innovative global procurement.
- Authors: Kumaresan J, Smith I, Arnold V, Evans P
- Issue date: 2004 Jan